The aim of this study is to investigate the use of benralizumab in patients with eosinophilic CRSwNP, and comorbid asthma, whose severity is consistent with a need for surgery despite ongoing treatment with intranasal corticosteroids and a history of treatment with systemic corticosteroids or prior surgery for CRSwNP. The effect of benralizumab 30 mg on nasal polyps will be assessed on top of standard of care therapy with INCS over a 56-week treatment period.
Health + well-being
April 16, 2024
8:30am
-
9:30am
Chateau Merrimack
Is it allergies or an intolerance? Do you have asthma symptoms or something that is mimicking those? Please join us in April to hear from Dr. Angela Ahuja about asthma and allergy. This is sure to be a great discussion!Join us: Tuesday, April 168:30 – 9:30 amFeatured SpeakerDr. Angela AhujaLowell General HospitalTopics